GRI Bio Q3 EPS $(1.28) Misses $(0.93) Estimate

GRI Bio (NASDAQ: GRI) reported quarterly losses of $(1.28) per share which missed the analyst consensus estimate of $(0.93) by 37.63 percent. This is a 88.79 percent increase over losses of $(11.42) per share from the same period last year.